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Abstract
Traditional differential expression tools are limited to detecting changes in overall expression, and fail to uncover the
rich information provided by single-cell level data sets. We present a Bayesian hierarchical model that builds upon
BASiCS to study changes that lie beyond comparisons of means, incorporating built-in normalization and quantifying
technical artifacts by borrowing information from spike-in genes. Using a probabilistic approach, we highlight genes
undergoing changes in cell-to-cell heterogeneity but whose overall expression remains unchanged. Control
experiments validate our method’s performance and a case study suggests that novel biological insights can be
revealed. Our method is implemented in R and available at https://github.com/catavallejos/BASiCS.
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Background
The transcriptomics revolution – moving from bulk sam-
ples to single-cell (SC) resolution – provides novel insights
into a tissue’s function and regulation. In particular,
single-cell RNA sequencing (scRNA-seq) has led to the
identification of novel sub-populations of cells in multi-
ple contexts [1–3]. However, compared to bulk RNA-seq,
a critical aspect of scRNA-seq data sets is an increased
cell-to-cell variability among the expression counts. Part
of this variance inflation is related to biological differ-
ences in the expression profiles of the cells (e.g., changes in
mRNA content and the existence of cell sub-populations
or transient states), which disappears when measuring
bulk gene expression as an average across thousands of
cells. Nonetheless, this increase in variability is also due
in part to technical noise arising from the manipulation of
small amounts of starting material, which is reflected in
weak correlations between technical replicates [4]. Such
technical artifacts are confounded with genuine transcrip-
tional heterogeneity and can mask the biological signal.
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Among others, one objective of RNA-seq experiments
is to characterize transcriptional differences between pre-
specified populations of cells (given by experimental con-
ditions or cell types). This is a key step for understanding
a cell’s fate and functionality. In the context of bulk RNA-
seq, two popular methods for this purpose are edgeR [5]
and DESeq2 [6]. However, these are not designed to cap-
ture features that are specific to scRNA-seq data sets.
In contrast, SCDE [7] has been specifically developed
to deal with scRNA-seq data sets. All of these meth-
ods target the detection of differentially expressed genes
based on log-fold changes (LFCs) of overall expression
between the populations. However, restricting the anal-
ysis to changes in overall expression does not take full
advantage of the rich information provided by scRNA-seq.
In particular – and unlike bulk RNA-seq – scRNA-seq
can also reveal information about cell-to-cell expression
heterogeneity. Critically, traditional approaches will fail
to highlight genes whose expression is less stable in any
given population but whose overall expression remains
unchanged between populations.
More flexible approaches, capable of studying changes
that lie beyond comparisons of means, are required to
characterize differences between distinct populations of
cells better. In this article, we develop a quantitative
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method to fill this gap, allowing the identification of
genes whose cell-to-cell heterogeneity pattern changes
between pre-specified populations of cells. In particular,
genes with less variation in expression levels within a spe-
cific population of cells might be under more stringent
regulatory control. Additionally, genes having increased
biological variability in a given population of cells could
suggest the existence of additional sub-groups within
the analyzed populations. To the best of our knowl-
edge, this is the first probabilistic tool developed for
this purpose in the context of scRNA-seq analyses. We
demonstrate the performance of our method using con-
trol experiments and by comparing expression patterns of
mouse embryonic stem cells (mESCs) between different
stages of the cell cycle.
Results and discussion
A statistical model to detect changes in expression
patterns for scRNA-seq data sets
We propose a statistical approach to compare expression
patterns between P pre-specified populations of cells.
It builds upon BASiCS [8], a Bayesian model for the
analysis of scRNA-seq data. As in traditional differential
expression analyses, for any given gene i, changes in over-
all expression are identified by comparing population-
specific expression rates μ(p)i (p = 1, . . . ,P), defined
as the relative abundance of gene i within the cells in
population p. However, the main focus of our approach
is to assess differences in biological cell-to-cell hetero-
geneity between the populations. These are quantified
through changes in population- and gene-specific bio-
logical over-dispersion parameters δ(p)i (p = 1, . . . ,P),
designed to capture residual variance inflation (after nor-
malization and technical noise removal) while attenuating
the well-known confounding relationship between mean
and variance in count-based data sets [9] (a similar con-
cept was defined in the context of bulk RNA-seq by [10],
using the term biological coefficient of variation). Impor-
tantly, such changes cannot be uncovered by standard
differential expression methods, which are restricted to
changes in overall expression. Hence, our approach pro-
vides novel biological insights by highlighting genes that
undergo changes in cell-to-cell heterogeneity between the
populations despite the overall expression level being pre-
served.
To disentangle technical from biological effects, we
exploit spike-in genes that are added to the lysis buffer
and thence theoretically present at the same amount
in every cell (e.g., the 92 ERCC molecules developed
by the External RNA Control Consortium [11]). These
provide an internal control or gold standard to estimate
the strength of technical variability and to aid normaliza-
tion. In particular, these control genes allow inference on
cell-to-cell differences in mRNA content, providing
additional information about the analyzed populations
of cells [12]. These are quantified through changes
between cell-specific normalizing constants φ(p)j (for
the jth cell within the pth population). Critically, as
described in Additional file 1: Note S1 and Fig. S1,
global shifts in mRNA content between populations
do not induce spurious differences when comparing
gene-specific parameters (provided the offset correction
described in ‘Methods’ is applied).
A graphical representation of our model is displayed in
Fig. 1 (based on a two-group comparison). It illustrates
how our method borrows information across all cells and
genes (biological transcripts and spike-in genes) to per-
form inference. Posterior inference is implemented via a
Markov chain Monte Carlo (MCMC) algorithm, gener-
ating draws from the posterior distribution of all model
parameters. Post-processing of these draws allows quan-
tification of supporting evidence regarding changes in
expression patterns (mean and over-dispersion). These
are measured using a probabilistic approach based on
tail posterior probabilities associated with decision rules,
where a probability cut-off is calibrated through the
expected false discovery rate (EFDR) [13].
Our strategy is flexible and can be combined with a
variety of decision rules, which can be altered to reflect
the biological question of interest. For example, if the
aim is to detect genes whose overall expression changes
between populations p and p′, a natural decision rule is
| log(μ(p)i /μ(p
′)
i )| > τ0, where τ0 ≥ 0 is an a priori cho-
sen biologically significant threshold for LFCs in overall
expression, to avoid highlighting genes with small changes
in expression that are likely to be less biologically relevant
[6, 14]. Alternatively, changes in biological cell-to-cell het-
erogeneity can be assessed using | log(δ(p)i /δ(p
′)
i )| > ω0,
for a given minimum tolerance threshold ω0 ≥ 0. This is
the main focus of this article. As a default option, we sug-
gest setting τ0 = ω0 = 0.4, which roughly coincides with
a 50 % increase in overall expression or over-dispersion in
whichever group of cells has the largest value (this choice
is also supported by the control experiments shown in this
article). To improve the interpretation of the genes high-
lighted by our method, these decision rules can also be
complemented by, e.g., requiring a minimum number of
cells where the expression of a gene is detected.
More details regarding the model setup and the
implementation of posterior inference can be found in
‘Methods’.
Alternative approaches for identifying changes in mean
expression
To date, most differential expression analyses of scRNA-
seq data sets have borrowed methodology from bulk
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Fig. 1 Graphical representation of our model for detecting changes in expression patterns (mean and over-dispersion) based on comparing two
predefined population of cells. The diagram considers expression counts of two genes (i is biological and i′ is technical) and two cells (jp and j′p) from
each population p = 1, 2. Observed expression counts are represented by square nodes. The central rhomboid node denotes the known input
number of mRNAmolecules for a technical gene i′ , which is assumed to be constant across all cells. The remaining circular nodes represent unknown
elements, using black to denote random effects and red to denote model parameters (fixed effects) that lie on the top of the model’s hierarchy.
Here, φ(p)j ’s and s
(p)
j ’s act as normalizing constants that are cell-specific and θp ’s are global over-dispersion parameters capturing technical variability,
which affect the expression counts of all genes and cells within each population. In this diagram, ν(p)j ’s and ρ
(p)
ij ’s represent random effects related to
technical and biological variability components, whose variability is controlled by θp ’s and δ
(p)
i ’s, respectively (see Additional file 1: Note 6.1). Finally,
μ
(p)
i ’s and δ
(p)
i ’s, respectively, measure the overall expression of a gene i and its residual biological cell-to-cell over-dispersion (after normalization,
technical noise removal and adjustment for overall expression) within each population. Colored areas highlight elements that are shared within a
gene and/or cell. The latter emphasizes how our model borrows information across all cells to estimate parameters that are gene-specific and all
genes to estimate parameters that are cell-specific. More details regarding the model setup can be found in the ‘Methods’ section of this article
RNA-seq literature (e.g., DESeq2 [6] and edgeR [5]).
However, such methods are not designed to cap-
ture features that are specific to SC-level experiments
(e.g., the increased levels of technical noise). Instead,
BASiCS, SCDE [7] and MAST [15] have been specifi-
cally developed with scRNA-seq data sets in mind. SCDE
is designed to detect changes in mean expression while
accounting for dropout events, where the expression of
a gene is undetected in some cells due to biological
variability or technical artifacts. For this purpose, SCDE
employs a two-component mixture model where nega-
tive binomial and low-magnitude Poisson components
model amplified genes and the background signal related
to dropout events, respectively. MAST is designed to cap-
ture more complex changes in expression, using a hurdle
model to study both changes in the proportion of cells
where a gene is expressed above background and in the
positive expression mean, defined as a conditional value –
given than the gene is expressed above background levels.
Additionally, MAST uses the fraction of genes that are
detectably expressed in each cell (the cellular detection
rate or CDR) as a proxy to quantify technical and bio-
logical artifacts (e.g., cell volume). SCDE and MAST rely
on pre-normalized expression counts. Moreover, unlike
BASiCS, SCDE and MAST use a definition of changes
in expression mean that is conceptually different to what
would be obtained based on a bulk population (which
would consider all cells within a group, regardless of
whether a gene is expressed above background or not).
The performance of these methods is compared in
Additional file 1: Note S2 using real and simulated
data sets. While control of the false discovery rate
(FDR) is not well calibrated for BASiCS when setting
τ0 = 0, this control is substantially improved when
increasing the LFC threshold to τ0 = 0.4 – which
is the default option we recommend (Additional file 1:
Table S1). Not surprisingly, the higher FDR rates of
BASiCS lead to higher sensitivity. In fact, our simula-
tions suggest that BASiCS can correctly identify more
genes that are differentially expressed than othermethods.
While this conclusion is based on synthetic data, it is
also supported by the analysis of the cell-cycle data set
described in [16] (see Additional file 1: Fig. S2), where
we observe that SCDE and MAST fail to highlight a
large number of genes for which a visual inspection
suggests clear changes in overall expression (Additional
file 1: Figs. S3 and S4). We hypothesize that this is
partly due to conceptual differences in the definition of
overall expression and, for MAST, the use of CDR as a
covariate.
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Alternative approaches for identifying changes in
heterogeneity of expression
To the best of our knowledge, BASiCS is the first prob-
abilistic tool to quantify gene-specific changes in the
variability of expression between populations of cells.
Instead, previous literature has focused on compar-
isons based on the coefficient of variation (CV), calcu-
lated from pre-normalized expression counts (e.g., [17]),
for which no quantitative measure of differential vari-
ability has been obtained. More recently, [9] proposed
a mean-corrected measure of variability to avoid the
confounding effect between mean expression and CV.
Nonetheless, the latter was designed to compare expres-
sion patterns for sets of genes, rather than for individual
genes.
Not surprisingly, our analysis suggests that a
quantification of technical variability is critical when
comparing variability estimates between cell populations
(Additional file 1: Note S3 and Fig. S5). In particular,
comparisons based on CV estimates can mask the bio-
logical signal if the strength of technical variability varies
between populations.
A control experiment: comparing single cells vs
pool-and-split samples
To demonstrate the efficacy of our method, we use
the control experiment described in [17], where sin-
gle mESCs are compared against pool-and-split (P&S)
samples, consisting of pooled RNA from thousands of
mESCs split into SC equivalent volumes. Such a con-
trolled setting provides a situation where substantial
changes in overall expression are not expected as, on
average, the overall expression of SCs should match
the levels measured in P&S samples. Additionally, the
design of P&S samples should remove biological variation,
leading to a homogeneous set of samples. Hence,
P&S samples are expected to show a genuine reduc-
tion in biological cell-to-cell heterogeneity compared to
SCs.
Here, we display the analysis of samples cultured in a 2i
media. Hyper-parameter values for μ(p)i ’s and δ
(p)
i ’s were
set to a2μ = a2δ = 0.5, so that extreme LFC estimates are
shrunk towards (−3, 3) (see ‘Methods’). However, varying
a2μ and a2δ leads to almost identical results (not shown),
suggesting that posterior inference is in fact dominated
by the data. In these data, expression counts correspond
to the number of molecules mapping to each gene within
each cell. This is achieved by using unique molecular
identifiers (UMIs), which remove amplification biases and
reduce sources of technical variation [18]. Our analysis
includes 74 SCs and 76 P&S samples (same inclusion cri-
teria as in [17]) and expression counts for 9378 genes
(9343 biological and 35 ERCC spikes) defined as those
with at least 50 detected molecules in total across all cells.
The R code used to perform this analysis is provided in
Additional file 2.
To account for potential batch effects, we allowed
different levels of technical variability to be estimated in
each batch (see Additional file 1: Note S4 and Fig. S6).
Moreover, we also performed an independent analysis of
each batch of cells. As seen in Additional file 1: Fig. S7,
the results based on the full data are roughly replicated in
each batch, suggesting that our strategy is able to remove
potential artifacts related to this batch effect.
As expected, our method does not reveal major changes
in overall expression between SCs and P&S samples as the
distribution of LFC estimates is roughly symmetric with
respect to the origin (see Fig. 2a) and the majority of genes
Fig. 2 Estimated LFCs in expression (mean and over-dispersion) when comparing SCs vs P&S samples (2i serum culture). Posterior medians of LFC in
(a) overall expression log(μ(SC)i /μ
(P&S)
i ) and (b) biological over-dispersion log(δ
(SC)
i /δ
(P&S)
i ) against the average between estimates of overall
expression rates for SCs and P&S samples. Average values are defined as a weighted average between groups, with weights given by the number of
samples within each group of cells. As expected, our analysis does not reveal major changes in expression levels between SC and P&S samples. In
fact, the distribution of estimated LFCs in overall expression is roughly symmetric with respect to the origin. In contrast, we infer a substantial
decrease in biological over-dispersion in the P&S samples. This is reflected by a skewed distribution of estimated LFCs in biological over-dispersion
towards positive values. LFC log-fold change, P&S pool-and-split, SC single cell
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are not classified as differentially expressed at 5 % EFDR
(see Fig. 3b). However, this analysis suggests that setting
the minimum LFC tolerance threshold τ0 equal to 0 is too
liberal as small LFCs are associated with high posterior
probabilities of changes in expression (see Fig. 3a) and the
number of differentially expressed genes is inflated (see
Fig. 3b). In fact, counter-intuitively, 4710 genes (≈50 %
of all analyzed genes) are highlighted to have a change
in overall expression when using τ0 = 0. This is par-
tially explained by the high nominal FDR rates displayed
in Additional file 1: Note S2.1 where, for τ0 = 0, FDR is
poorly calibrated when simulating under the null model.
In addition, we hypothesize this heavy inflation is also due
to small but statistically significant differences in expres-
sion that are not biologically meaningful. In fact, the num-
ber of genes whose overall expression changes is reduced
to 559 (≈6 % of all analyzed genes) when setting τ0 =
0.4. As discussed earlier, this minimum threshold roughly
coincides with a 50 % increase in overall expression
and with the 90th percentile of empirical LFC estimates
when simulating under the null model (no changes in
expression). Posterior inference regarding biological over-
dispersion is consistent with the experimental design,
where the P&S samples are expected to have more
homogeneous expression patterns. In fact, as shown in
Fig. 2b, the distribution of estimated LFCs in biological
a b
Fig. 3 Summary of changes in expression patterns (mean and over-dispersion) for SCs vs P&S samples (EFDR = 5 %). a Volcano plots showing
posterior medians of LFCs against estimated tail posterior probabilities. Left panels relate to the test where we assess if the absolute LFC in overall
expression between SCs and P&S samples exceeds a minimum threshold τ0. Estimates for LFCs in overall expression are truncated to the range
(−1.5, 1.5). Pink and green dots represent genes highlighted to have higher overall expression in the SC and P&S samples, respectively. Right panels
relate to the test where we assess if the absolute LFC in biological over-dispersion between SC and P&S samples exceeds a minimum threshold ω0.
In all cases, horizontal dashed lines are located at probability cut-offs defined by EFDR = 5 %. Pink and green dots represent genes highlighted to have
higher biological over-dispersion in the SC and P&S samples, respectively. b Bins in the horizontal axis summarize changes in overall expression
between the groups. We use SC+ and P&S+ to denote that higher overall expression was detected in SC and P&S samples, respectively [the central
group of bars (No diff.) corresponds to those genes where no significant differences were found]. Colored bars within each group summarize
changes in biological over-dispersion between the groups. We use pink and green bars to denote higher biological over-dispersion in SC and P&S+
samples, respectively (and gray to denote no significant differences were found). The numbers of genes are displayed in log-scale. LFC log-fold
change, P&S pool-and-split, SC single cell
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over-dispersion is skewed towards positive values (higher
biological over-dispersion in SCs). This is also supported
by the results shown in Fig. 3b, where slightly more than
2000 genes exhibit increased biological over-dispersion
in SCs and almost no genes (≈60 genes) are high-
lighted to have higher biological over-dispersion in the
P&S samples (EFDR = 5 %). In this case, the choice
of ω0 is less critical (within the range explored here).
This is illustrated by the left panels in Fig. 3a, where
tail posterior probabilities exceeding the cut-off defined
by EFDR = 5 % correspond to similar ranges of LFC
estimates.
mESCs across different cell-cycle stages
Our second example shows the analysis of the mESC data
set presented in [16], which contains cells where the cell-
cycle phase is known (G1, S and G2M). After applying
the same quality control criteria as in [16], our analy-
sis considers 182 cells (59, 58 and 65 cells in stages G1,
S and G2M, respectively). To remove genes with consis-
tently low expression across all cells, we excluded those
genes with less than 20 reads per million (RPM), on aver-
age, across all cells. After this filter, 5,687 genes remain
(including 5,634 intrinsic transcripts, and 53 ERCC spike-
in genes). The R code used to perform this analysis is
provided in Additional file 3.
As a proof of concept, to demonstrate the effi-
cacy of our approach under a negative control, we
performed permutation experiments, where cell
labels were randomly permuted into three groups
(containing 60, 60 and 62 samples, respectively). In
this case, our method correctly infers that mRNA
content as well as gene expression profiles do not
vary across groups of randomly permuted cells
(Fig. 4).
As cells progress through the cell cycle, cellular mRNA
content increases. In particular, our model infers that
mRNA content is roughly doubled when comparing cells
in G1 vs G2M, which is consistent with the duplication
of genetic material prior to cell division (Fig. 5a). Our
analysis suggests there are no major shifts in expression
levels between cell-cycle stages (Fig. 5b and upper tri-
angular panels in Fig. 5d). Nonetheless, a small number
of genes are identified as displaying changes in over-
all expression between cell-cycle phases at 5 % EFDR
for τ0 = 0.4 (Fig. 6). To validate our results, we per-
formed gene ontology (GO) enrichment analysis within
those genes classified as differentially expressed between
cell-cycle phases (see Additional file 3). Not surprisingly,
we found an enrichment of mitotic genes among the
545 genes classified as differentially expressed between
G1 and G2M cells. In addition, the 209 differentially
expressed genes between S and G2M are enriched for
regulators of cytokinesis, which is the final stage of the
cell cycle where a progenitor cell divides into two daughter
cells [19].
Our method suggests a substantial decrease in biolog-
ical over-dispersion when cells move from G1 to the S
phase, followed by a slight increase after the transition
from S to the G2M phase (see Fig. 5c and the lower trian-
gular panels in Fig. 5d). This is consistent with the findings
in [19], where the increased gene expression variability
observed in G2M cells is attributed to an unequal distri-
bution of genetic material during cytokinesis and the S
phase is shown to have themost stable expression patterns
within the cell cycle. Here, we discuss GO enrichment of
those genes whose overall expression rate remains con-
stant (EFDR = 5 %, τ0 = 0.4) but that exhibit changes
in biological over-dispersion between cell-cycle stages
(EFDR = 5 %, ω0 = 0.4). Critically, these genes will not
be highlighted by traditional differential expression tools,
which are restricted to differences in overall expression
rates. For example, among the genes with higher biologi-
cal over-dispersion in G1 with respect to the S phase, we
found an enrichment of genes related to protein dephos-
phorylation. These are known regulators of the cell cycle
[20]. Moreover, we found that genes with lower biologi-
cal over-dispersion in G2M cells are enriched for genes
related to DNA replication checkpoint regulation (which
delays entry intomitosis until DNA synthesis is completed
[21]) relative to G1 cells and mitotic cytokinesis when
comparing to S cells. Both of these processes are likely to
be more tightly regulated in the G2M phase. A full table
with GO enrichment analysis of the results described here
is provided in Additional file 3.
Conclusions
Our method provides a quantitative tool to study changes
in gene expression patterns between pre-specified popu-
lations of cells. Unlike traditional differential expression
analyses, our model is able to identify changes in expres-
sion that are not necessarily reflected by shifts in the
mean. This allows a better understanding of the differ-
ences between distinct populations of cells. In particular,
we focus on the detection of genes whose residual bio-
logical heterogeneity (after normalization and technical
noise removal) varies between the populations. This is
quantified through biological over-dispersion parameters,
which capture variance inflation with respect to the level
that would be expected in a homogeneous population
of cells while attenuating the well-known confounding
relationship between mean and variance in count-based
data sets. Despite this, several case studies (including the
ones displayed in the manuscript and other examples ana-
lyzed throughout model development) suggest that – for a
homogeneous population of cells – there is a strong rela-
tionship between posterior estimates of overall expression
parameters μ(p)i and over-dispersion parameters δ
(p)
i (this
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a b c
d
Fig. 4 Posterior estimates of model parameters based on random permutations of the mESC cell-cycle data set. For a single permuted data set:
a Empirical distribution of posterior medians for mRNA content normalizing constants φjp across all cells. b Empirical distribution of posterior
medians for gene-specific expression rates μip across all genes. c Empirical distribution of posterior medians for gene-specific biological
over-dispersion parameters δip across all genes. d As an average across ten random permutations. Upper diagonal panels compare estimates for
gene-specific expression rates μip between groups of cells. Lower diagonal panels compare gene-specific biological over-dispersion parameters δip
between groups of cells
is broken when analyzing heterogeneous populations,
see Section S8 in [8]). This is illustrated in Additional
file 1: Note S5 using the cell-cycle data set analyzed
here (Additional file 1: Figs. S8 and S9). Due to this
interplay between overall expression and over-dispersion,
the interpretation of over-dispersion parameters δ(p)i
requires careful consideration. In particular, it is not
trivial to interpret differences between δ(p)i ’s when the
μ
(p)
i ’s also change. As a consequence, our analysis focuses
on genes undergoing changes in over-dispersion but
whose overall expression remains unchanged. This set of
genes can provide novel biological insights that would
not be uncovered by traditional differential expression
analysis tools.
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a b
d
c
Fig. 5 Posterior estimates of model parameters for mESCs across different cell-cycle phases. a Empirical distribution of posterior medians for mRNA
content normalizing constants φ(p)j across all cells. b Empirical distribution of posterior medians for gene-specific expression rates μ
(p)
i across all
genes. c Empirical distribution of posterior medians for gene-specific biological over-dispersion parameters δ(p)i across all genes. d Upper diagonal
panels compare estimates for gene-specific expression rates μ(p)i between groups of cells. Lower diagonal panels compare gene-specific biological
over-dispersion parameters δ(p)i between groups of cells. While our results suggest there are no major shifts in mean expression between cell-cycle
stages, our results suggest a substantial decrease in biological over-dispersion when cells move from G1 to the S phase, followed by a slight increase
after the transition from S to the G2M phase (to give a rough quantification of this statement, panel (d) includes the percentage of point estimates
that lie on each side of the diagonal line)
A decision rule to determine changes in expression
patterns is defined through a probabilistic approach
based on tail posterior probabilities and calibrated
using the EFDR. The performance of our method was
demonstrated using a controlled experiment where we
recovered the expected behavior of gene expression
patterns.
One caveat of our approach is the limited interpretation
of the over-dispersion parameter when a gene is not
expressed in a given population of cells or when the
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Fig. 6 Summary of changes in expression patterns (mean and over-dispersion) for the mESC cell-cycle data set (EFDR = 5 %). Bins in the horizontal
axis summarize changes in overall expression between each pair of groups. We use G1+, S+ and G2M+ to denote that higher overall expression was
detected in cell-cycle phase G1, S and G2M, respectively [the central group of bars (No diff.) corresponds to those genes where no significant
differences were found]. Colored bars within each group summarize changes in biological over-dispersion between the groups. We use pink, green
and yellow bars to denote higher biological over-dispersion in cell-cycle phases G1, S and G2M, respectively (and gray to denote no significant
differences were found). The numbers of genes are displayed in log-scale
expression of a gene is only detected in a small proportion
of cells (e.g., high expression in a handful of cells but no
expression in the remaining cells). These situations will
be reflected in low and high estimates of δ(p)i , respec-
tively. However, the biological relevance of these estimates
is not clear. Hence, to improve the interpretation of the
genes highlighted by our method, we suggest comple-
menting the decision rules presented here by conditioning
the results of the test on aminimumnumber of cells where
the expression of a gene is detected.
Currently, our approach requires predefined popula-
tions of cells (e.g., defined by cell types or experimen-
tal conditions). However, a large number of scRNA-seq
experiments involve a mixed population of cells, where
cell types are not known a priori (e.g., [1–3]). In such
cases, expression profiles can be used to cluster cells
into distinct groups and to characterize markers for such
sub-populations. Nonetheless, unknown group structures
introduce additional challenges for normalization and
quantification of technical variability since, e.g., noise
levels can vary substantially between different cell popu-
lations. A future extension of our work is to combine the
estimation procedure within our model with a clustering
step, propagating the uncertainty associated with each of
these steps into downstream analysis. In the meantime, if
the analyzed population of cells contains a sub-population
structure, we advise the user to cluster cells first (e.g.,
using a rank-based correlation, which is more robust to
normalization), thus defining groups of cells that can be
used as an input for BASiCS. This step will also aid the
interpretation of model parameters that are gene-specific.
Until recently, most scRNA-seq data sets consisted of
hundreds (and sometimes thousands) of cells. However,
droplet-based approaches [22, 23] have recently allowed
parallel sequencing of substantially larger numbers of cells
in an effective manner. This brings additional challenges
to the statistical analysis of scRNA-seq data sets (e.g., due
to the existence of unknown sub-populations, requiring
unsupervised approaches). In particular, current proto-
cols do not allow the addition of technical spike-in genes.
As a result, the deconvolution of biological and techni-
cal artifacts has become less straightforward. Moreover,
the increased sample sizes emphasize the need for more
computationally efficient approaches that are still able to
capture the complex structure embedded within scRNA-
seq data sets. To this end, we foresee the use of parallel
programming as a tool for reducing computing times.
Additionally, we are also exploring approximated poste-
rior inference based, for example, on an integrated nested
Laplace approximation [24].
Finally, our approach lies within a generalized linear
mixed model framework. Hence, it can be easily extended
to include additional information such as covariates (e.g.,
cell-cycle stage, gene length and GC content) and exper-
imental design (e.g., batch effects) using fixed and/or
random effects.
Methods
A statistical model to detect changes in expression
patterns for scRNA-seq data sets
In this article, we introduce a statistical model for iden-
tifying genes whose expression patterns change between
predefined populations of cells (given by experimental
conditions or cell types). Such changes can be reflected
via the overall expression level of each gene as well as
through changes in cell-to-cell biological heterogeneity.
Our method is motivated by features that are specific to
scRNA-seq data sets. In this context, it is essential to nor-
malize and remove technical artifacts appropriately from
the data before extracting the biological signal. This is
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particularly critical when there are substantial differences
in cellular mRNA content, amplification biases and other
sources of technical variation. For this purpose, we exploit
technical spike-in genes, which are added at the (theoreti-
cally) same quantity to each cell’s lysate. A typical example
is the set of 92 ERCCmolecules developed by the External
RNA Control Consortium [11]. Our method builds upon
BASiCS [8] and can perform comparisons between multi-
ple populations of cells using a single model. Importantly,
our strategy avoids stepwise procedures where data sets
are normalized prior to any downstream analysis. This is
an advantage over methods using pre-normalized counts,
as the normalization step can be distorted by technical
artifacts.
We assume that there are P groups of cells to be com-
pared, each containing np cells (p = 1, . . . ,P). Let X(p)ij be
a random variable representing the expression count of a
gene i (i = 1, . . . , q) in the jth cell from group p. With-
out loss of generality, we assume the first q0 genes are
biological and the remaining q − q0 are technical spikes.
Extending the formulation in BASiCS, we assume that
E
(
X(p)ij
)
=
{
φ
(p)
j s
(p)
j μ
(p)
i , i = 1, . . . , q0;
s(p)j μ
(p)
i , i = q0 + 1, . . . , q.
and (1)
CV2
(
X(p)ij
)
=
{
(φ
(p)
j s
(p)
j μ
(p)
i )
−1 + θp + δ(p)i (θp + 1), i = 1, . . . , q0;
(s(p)j μ
(p)
i )
−1 + θp, i = q0 + 1, . . . , q,
(2)
with μ(p)i ≡ μi for i = q0 + 1, . . . , q and where CV
stands for coefficient of variation (i.e., the ratio between
standard deviation and mean). These expressions are the
result of a Poisson hierarchical structure (see Additional
file 1: Note S6.1). Here, φ(p)j ’s act as cell-specific nor-
malizing constants (fixed effects), capturing differences
in input mRNA content across cells (reflected by the
expression counts of intrinsic transcripts only). A second
set of normalizing constants, s(p)j ’s, capture cell-specific
scale differences affecting the expression counts of all
genes (intrinsic and technical). Among others, these dif-
ferences can relate to sequencing depth, capture efficiency
and amplification biases. However, a precise interpreta-
tion of the s(p)j ’s varies across experimental protocols, e.g.,
amplification biases are removed when using UMIs [18].
In addition, θp’s are global technical noise parameters
controlling the over-dispersion (with respect to Poisson
sampling) of all genes within group p. The overall expres-
sion rate of a gene i in group p is denoted by μ(p)i . These
are used to quantify changes in the overall expression of
a gene across groups. Similarly, the δ(p)i ’s capture residual
over-dispersion (beyond what is due to technical artifacts)
of every gene within each group. These so-called biolog-
ical over-dispersion parameters relate to heterogeneous
expression of a gene across cells. For each group, stable
housekeeping-like genes lead to δ(p)i ≈ 0 (low residual
variance in expression across cells) and highly variable
genes are linked to large values of δ(p)i . A novelty of our
approach is the use of δ(p)i to quantify changes in biological
over-dispersion. Importantly, this attenuates confounding
effects due to changes in overall expression between the
groups.
A graphical representation of this model is displayed in
Fig. 1. To ensure identifiability of all model parameters, we
assume that μ(p)i ’s are known for the spike-in genes (and
given by the number of spike-in molecules that are added
to each well). Additionally, we impose the identifiability
restriction
1
np
np∑
j=1
φ
(p)
j = 1, for p = 1, . . . ,P. (3)
Here, we discuss the priors assigned to parameters that
are gene- and group-specific (see Additional file 1: Note
S6.2 for the remaining elements of the prior). These are
given by
μ
(p)
i
iid∼ logN (0, a2μ) and δ(p)i iid∼ logN (0, a2δ)
for i = 1, . . . , q0.
(4)
Hereafter, without loss of generality, we simplify our
notation to focus on two-group comparisons. This
is equivalent to assigning Gaussian prior distributions
for LFCs in overall expression (τi) or biological over-
dispersion (ωi). In such a case, it follows that
τi ≡ log
(
μ
(1)
i
/
μ
(2)
i
)
∼ N (0, 2a2μ) and
ωi ≡ log
(
δ
(1)
i
/
δ
(2)
i
)
∼ N (0, 2a2δ) . (5)
Hence, our prior is symmetric, meaning that we do
not a priori expect changes in expression to be skewed
towards either group of cells. Values for a2μ and a2δ can
be elicited using an expected range of values for LFC
in expression and biological over-dispersion, respectively.
The latter is particularly useful in situations where a gene
is not expressed (or very lowly expressed) in one of the
groups, where, e.g., LFCs in overall expression are unde-
fined (the maximum likelihood estimate of τi would be
±∞, the sign depending on which group expresses gene
i). A popular solution to this issue is the addition of
pseudo-counts, where an arbitrary number is added to all
expression counts (in all genes and cells). This strategy is
also adopted in models that are based on log-transformed
expression counts (e.g., [15]). While the latter guaran-
tees that τi is well defined, it leads to artificial estimates
for τi (see Table 1). Instead, our approach exploits an
informative prior (indexed by a2μ) to shrink extreme esti-
mates of τi towards an expected range. This strategy leads
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Table 1 Synthetic example to illustrate the effect of addition of pseudo-counts over the estimation of LFCs in overall expression
Empirical Adding 0.5 Adding 1
estimate pseudo-counts pseudo-count
Overall expression rate in population 1 (μ(1)i ) 10 10.5 11
Overall expression rate in population 2 (μ(2)i ) 0 0.5 1
LFC in overall expression 1 vs 2 +∞ 3.04 2.40
For simplicity, we assume that normalization is not required so that pseudo-counts are linearly reflected in the overall expression rates. While pseudo-counts introduce an
additive effect, LFC estimates measure changes on a multiplicative scale. Hence, addition of pseudo-counts leads to an artificial deflation of LFC estimates. As a consequence,
such estimates cannot be meaningfully interpreted
to a meaningful shrinkage strength, which is based on
prior knowledge. Importantly – and unlike the addition of
pseudo-counts – our approach is also helpful when com-
paring biological over-dispersion between the groups. In
fact, if a gene i is not expressed in one of the groups, this
will lead to a non-finite estimate of ωi (if all expression
counts in a group are equal to zero, the correspond-
ing estimate of the biological over-dispersion parameters
would be equal to zero). Adding pseudo-counts cannot
resolve this issue, but imposing an informative prior for ωi
(indexed by a2ω) will shrink estimates towards the appro-
priate range.
Generally, posterior estimates of τi and ωi are robust to
the choice of a2μ and a2δ , as the data is informative and
dominates posterior inference. In fact, these values are
only influential when shrinkage is needed, e.g., when there
are zero total counts in one of the groups. In such cases,
posterior estimates of τi andωi are dominated by the prior,
yet the method described below still provides a tool to
quantify evidence of changes in expression. As a default
option, we use a2μ = a2δ = 0.5 leading to τi,ωi ∼ N(0, 1).
These default values imply that approximately 99 % of
the LFCs in overall expression and over-dispersion are
expected a priori to lie in the interval (−3, 3). This range
seems reasonable in light of the case studies we have
explored. If a different range is expected, this can be easily
modified by the user by setting different values for a2μ and
a2δ .
Posterior samples for all model parameters are gener-
ated via an adaptive Metropolis within a Gibbs sampling
algorithm [25]. A detailed description of our implementa-
tion can be found in Additional file 1: Note S6.3.
Post hoc correction of global shifts in input mRNA content
between the groups
The identifiability restriction in Eq. 3 applies only to cells
within each group. As a consequence, if they exist, global
shifts in cellular mRNA content between groups (e.g., if all
mRNAs were present at twice the level in one population
related to another) are absorbed by the μ(p)i ’s. To assess
changes in the relative abundance of a gene, we adopt a
two-step strategy where: (1) model parameters are esti-
mated using the identifiability restriction in Eq. 3 and (2)
global shifts in endogenous mRNA content are treated as
a fixed offset and corrected post hoc. For this purpose,
we use the sum of overall expression rates (intrinsic genes
only) as a proxy for the total mRNA content within each
group. Without loss of generality, we use the first group
of cells as a reference population. For each population
p (p = 1, . . . ,P), we define a population-specific offset
effect:
	p =
( q0∑
i=1
μ
(p)
i
)/( q0∑
i=1
μ
(1)
i
)
(6)
and perform the following offset correction:
μ˜
(p)
i = μ(p)i
/
	p, φ˜(p)j = φ(p)j × 	p,
i = 1, . . . , q0; jp = 1, . . . , np.
(7)
This is equivalent to replacing the identifiability restric-
tion in Eq. 3 by
1
np
np∑
j=1
φ
(p)
j = 	p, for p = 1, . . . ,P. (8)
Technical details regarding the implementation of this
post hoc offset correction are explained in Additional file
1: Note S6.4. The effect of this correction is illustrated in
Fig. 7 using the cell-cycle data set described in the main
text. As an alternative, we also explored the use of the
ratio between the total intrinsic counts over total spike-in
counts to define a similar offset correction based on
	′p =
⎛
⎝median
j=1,...,np
⎧⎨
⎩
∑q0
i=1 X
(p)
ij∑q
i=q0+1 X
(p)
ij
⎫⎬
⎭
⎞
⎠/
⎛
⎝median
j=1,...,n1
⎧⎨
⎩
∑q0
i=1 X
(1)
ij∑q
i=q0+1 X
(1)
ij
⎫⎬
⎭
⎞
⎠ .
(9)
For the cell-cycle data set, both alternatives are equiva-
lent. Nonetheless, the first option is more robust in cases
where a large number of differentially expressed genes are
present. Hereafter, we useμ(p)i and φ
(p)
j to denote μ˜
(p)
i and
φ˜
(p)
j , respectively.
A probabilistic approach to quantify evidence of changes
in expression patterns
A probabilistic approach is adopted, assessing changes in
expression patterns (mean and over-dispersion) through a
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Fig. 7 Post hoc offset correction for cell-cycle data set. Upper panels display posterior medians for LFC in overall expression against the weighted
average between estimates of overall expression rates for G1, S and G2M cells (weights defined by the number of cells in each group). Lower panels
illustrate the effect of the offset correction upon the empirical distribution of posterior estimates for mRNA content normalizing constants φ(p)j .
These figures illustrate a shift in mRNA content throughout cell-cycle phases. In particular, our model infers that cellular mRNA is roughly duplicated
when comparing G1 to G2M cells. LFC log-fold change
simple and intuitive scale of evidence. Our strategy is flex-
ible and can be combined with a variety of decision rules.
In particular, here we focus on highlighting genes whose
absolute LFC in overall expression and biological over-
dispersion between the populations exceeds minimum
tolerance thresholds τ0 and ω0, respectively (τ0,ω0 ≥ 0),
set a priori. The usage of such minimum tolerance lev-
els for LFCs in expression has also been discussed in [14]
and [6] as a tool to improve the biological significance
of detected changes in expression and to improve upon
FDRs.
For a given probability threshold αM (0.5 < αM < 1),
a gene i is identified as exhibiting a change in overall
expression between populations p and p′ if
πMipp′(τ0) ≡ P(| log(μ(p)i /μ(p
′)
i )| > τ0|{data}) > αM ,
i = 1, . . . , q0.
(10)
If τ0 → 0, πMi (τ0) → 1 becoming uninformative to
detect changes in expression. As in [26], in the limiting
case where τ0 = 0, we define
πMipp′(0) = 2max
{
π˜Mipp′ , 1 − π˜Mipp′
}
− 1 (11)
with
π˜Mipp′ = P
(
log
(
μ
(p)
i /μ
(p′)
i
)
> 0 | {data}
)
. (12)
A similar approach is adopted to study changes in bio-
logical over-dispersion between populations p and p′,
using
πDipp′(ω0) ≡ P
(
| log
(
δ
(p)
i /δ
(p′)
i
)
| > ω0|{data}
)
> αD ,
(13)
for a fixed probability threshold αD (0.5 < αD < 1). In line
with Eqs. 11 and 12, we also define
πDipp′(0) = 2max
{
π˜Dipp′ , 1 − π˜Dipp′
}
− 1 (14)
with
π˜Dipp′ = P
(
log
(
δ
(p)
i /δ
(p′)
i
)
> 0 | {data}
)
. (15)
Evidence thresholds αM and αD can be fixed a priori.
Otherwise, these can be defined by controlling the EFDR
[13]. In our context, these are given by
EFDRαM (τ0) =
∑q0
i=1
(
1 − πMi (τ0)
)
I
(
πMi (τ0) > αM
)
∑q0
i=1 I
(
πMi (τ0) > αM
)
(16)
and
EFDRαD (ω0) =
∑q0
i=1
(
1 − πDi (ω0)
)
I
(
πDi (ω0) > αD
)
∑q0
i=1 I
(
πDi (ω0) > αD
) ,
(17)
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where I(A) = 1 if event A is true, 0 otherwise. Critically,
the usability of this calibration rule relies on the existence
of genes under both the null and the alternative hypoth-
esis (i.e., with and without changes in expression). While
this is not a practical limitation in real case studies, this
calibration might fail to return a value in benchmark data
sets (e.g., simulation studies), where there are no changes
in expression. As a default, if EFDR calibration is not
possible, we set αM = αD = 0.90.
The posterior probabilities in Eqs. 10, 11, 13 and 14
can be easily estimated – as a post-processing step –
once the model has been fitted (see Additional file 1:
Note S6.5). In addition, our strategy is flexible and can
be easily extended to investigate more complex hypothe-
ses, which can be defined post hoc, e.g., to identify
those genes that show significant changes in cell-to-
cell biological over-dispersion but that maintain a con-
stant level of overall expression between the groups,
or conditional decision rules where we require a mini-
mum number of cells where the expression of a gene is
detected.
Software
Our implementation is freely available as an R package
[27], using a combination of R and C++ functions through
the Rcpp library [28]. This can be found in https://github.
com/catavallejos/BASiCS, released under the GPL license.
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